GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 281 filers reported holding GW PHARMACEUTICALS PLC in Q4 2018. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $424,000 | -54.4% | 3,688 | -31.6% | 0.01% | -50.0% |
| Q2 2019 | $929,000 | -15.1% | 5,388 | -17.0% | 0.01% | -20.0% |
| Q1 2019 | $1,094,000 | -20.8% | 6,488 | -18.9% | 0.02% | -11.8% |
| Q3 2018 | $1,382,000 | +136.6% | 7,998 | +39.1% | 0.02% | +142.9% |
| Q3 2017 | $584,000 | +1.4% | 5,750 | 0.0% | 0.01% | 0.0% |
| Q2 2017 | $576,000 | -81.2% | 5,750 | -77.3% | 0.01% | -81.1% |
| Q1 2017 | $3,066,000 | -19.7% | 25,350 | -25.8% | 0.04% | -24.5% |
| Q4 2016 | $3,816,000 | +1.2% | 34,150 | +20.2% | 0.05% | +8.9% |
| Q3 2016 | $3,770,000 | -26.2% | 28,400 | -49.1% | 0.04% | +40.6% |
| Q2 2016 | $5,110,000 | +171.8% | 55,800 | +114.2% | 0.03% | +28.0% |
| Q1 2016 | $1,880,000 | +138.6% | 26,050 | +129.5% | 0.02% | +127.3% |
| Q4 2015 | $788,000 | -24.0% | 11,350 | 0.0% | 0.01% | -21.4% |
| Q3 2015 | $1,037,000 | -17.6% | 11,350 | +10.7% | 0.01% | -6.7% |
| Q2 2015 | $1,259,000 | +452.2% | 10,250 | +310.0% | 0.02% | +400.0% |
| Q1 2015 | $228,000 | – | 2,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital Management, LLC | 86,069 | $18,668,000 | 8.69% |
| BARDIN HILL MANAGEMENT PARTNERS LP | 170,108 | $36,897,000 | 6.84% |
| HARVEST MANAGEMENT LLC | 44,100 | $9,565,000 | 5.72% |
| Twin Securities, Inc. | 39,541 | $8,576,000 | 5.50% |
| TIG Advisors, LLC | 572,743 | $124,228,000 | 4.67% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 787,500 | $170,810,000 | 4.63% |
| First Trust Capital Management L.P. | 105,822 | $22,953,000 | 4.49% |
| Pentwater Capital Management LP | 2,102,104 | $455,946,000 | 4.35% |
| OMNI PARTNERS LLP | 403,061 | $87,424,000 | 4.31% |
| SPRING CREEK CAPITAL LLC | 370,000 | $80,253,000 | 3.47% |